NIH Reporter #5K08CA279499-03

NCI Solicitation: Research Services for Regenerative Reprogramming in Colorectal Cancer

This opportunity from the National Cancer Institute (NCI) seeks research services to address regenerative reprogramming in colorectal cancer, specifically targeting mechanisms of cancer therapy resistance. - Government Buyer: - National Cancer Institute (NCI), Houston, Texas - Products/Services Requested: - Research services focused on regenerative reprogramming in colorectal cancer - Emphasis on advanced genomic and cellular technologies - Translational research with immediate clinical impact - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique/Notable Requirements: - Expertise in advanced genomics, cellular technologies, and translational cancer research - Project aims to overcome cancer therapy resistance - Estimated Contract Value: - $292,594 - No detailed product or service line items or part numbers are specified - Solicitation is open for bids; no response deadline or bid format provided

Description

This is a research project funded by the NIH/NCI focusing on cancer therapy resistance, specifically targeting regenerative reprogramming in colorectal cancer. The project involves advanced genomic and cellular technologies, with a focus on translational research to develop immediate clinical impact. It is an active solicitation by the National Cancer Institute (NCI) located in Houston, Texas. The estimated contract value is $292,594. No specific response deadline or bid format is provided.

View original listing